Nanohale AG (ETR:FYB) | WebDisclosure

PRESS RELEASE

published on 09/17/2025 at 06:30, 9 months 8 days ago

Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD

Agreement Formycon Eylea Biosimilar Horus Pharma Baiama Brand
BRIEF

published on 08/13/2025 at 06:35, 10 months 12 days ago

Formycon confirme ses perspectives pour l'ensemble de l'année après des développements stratégiques

Formycon AG Obligations D'entreprise Orientations Financières 2025 Marché Des Biosimilaires FYB202 Et FYB206
BRIEF

published on 08/13/2025 at 06:35, 10 months 12 days ago

Formycon Affirms Full-Year Outlook After Strategic Developments

Formycon AG Corporate Bond Biosimilar Market 2025 Financial Guidance FYB202 & FYB206
PRESS RELEASE

published on 08/13/2025 at 06:30, 10 months 12 days ago

Formycon confirms full-year guidance following business development in line with plan – working capital raised
Formycon AG confirms full-year guidance with successful business development. Working capital raised through oversubscribed corporate bond. Strong second half expected

Working Capital Business Development Formycon AG Corporate Bond Full-year Guidance
BRIEF

published on 08/04/2025 at 11:50, 10 months 21 days ago

Formycon AG obtient une note « fort achat » suite à des développements stratégiques

Formycon AG Emission D'obligations Mise À Jour Financière Recherche Sur Les Actions Lancement Du FYB202
BRIEF

published on 08/04/2025 at 11:50, 10 months 21 days ago

Formycon AG Gains Strong Buy Rating Amid Strategic Developments

Formycon AG Bond Issue Financial Update Equity Research FYB202 Launch
PRESS RELEASE

published on 08/04/2025 at 11:45, 10 months 21 days ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Formycon AG analysis, maintaining BUY rating with increased target price of €49. Company aims for 2025 revenue of €55-65m and improved financial position after new corporate bond issuance

First Berlin Equity Research BUY Rating Formycon AG Target Price Corporate Bond Issuance
BRIEF

published on 07/30/2025 at 06:35, 10 months 26 days ago

Formycon organise une conférence téléphonique et une participation à la conférence des investisseurs

Conseil D'administration Formycon AG Conférence Téléphonique Conférences D'investisseurs Résultats Financiers 2025
BRIEF

published on 07/30/2025 at 06:35, 10 months 26 days ago

Formycon Schedules Conference Call and Investor Conference Participation

Conference Call Investor Conferences Formycon AG Management Board 2025 Financial Results
PRESS RELEASE

published on 07/30/2025 at 06:30, 10 months 26 days ago

Formycon invites to conference call on 2025 half-year results and announces participation in international investor conferences in the 3rd quarter of 2025
Formycon AG to discuss 2025 half-year results in conference call and attend international investor conferences in the 3rd quarter of 2025. Details and registration info provided

Conference Call Investor Conferences Formycon AG Biosimilars 2025 Half-Year Results

Published on 06/25/2026 at 15:30, 5 hours 2 minutes ago

Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/25/2026 at 15:00, 5 hours 32 minutes ago

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend
Published on 06/25/2026 at 14:30, 6 hours 2 minutes ago

Unusual Machines Expands Orlando Manufacturing Footprint to Support Battery Operations
Published on 06/25/2026 at 14:01, 6 hours 31 minutes ago

Worksport (NASDAQ:WKSP) Regains $1 Bid Price Requirement, Announces CEO Town Hall, Highlights Multiple Recent Growth Drivers in CEO Letter
Published on 06/25/2026 at 14:00, 6 hours 32 minutes ago

Horizon Aircraft's Leadership Team to Participate at Farnborough International Airshow 2026

View all ACCESSWIRE

Published on 06/25/2026 at 19:00, 1 hour 31 minutes ago

EQS-Adhoc: H&R GmbH & Co. KGaA resolves to prepare for the transition from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
Published on 06/25/2026 at 18:59, 1 hour 32 minutes ago

OHB Digital Connect completes upgrade of military ground stations
Published on 06/25/2026 at 18:40, 1 hour 51 minutes ago

Texas Cardiac Arrhythmia Institute at St. David's Medical Center hosts international conference on complex cardiac arrhythmias
Published on 06/25/2026 at 18:30, 2 hours 2 minutes ago

Delisting of Northern Data AG Shares - Munich Stock Exchange Decides on the Timeline
Published on 06/25/2026 at 18:00, 2 hours 32 minutes ago

EUROPLASMA: Projet de cession des activités de défense : poursuite des discussions

View all EQS

Published on 06/25/2026 at 18:45, 1 hour 46 minutes ago

Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 2 hours 2 minutes ago

Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 2 hours 42 minutes ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 06/25/2026 at 17:50, 2 hours 42 minutes ago

DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 06/25/2026 at 15:58, 4 hours 33 minutes ago

260625 BENETEAU Transactions sur actions propres

View all LES ECHOS COMFI WIRE

News